Citius Oncology expands international distribution of Lymphir (denileukin diftitox-cxdl) to European Union through exclusive agreement with Uniphar
Citius Oncology Inc., the oncology-focused subsidiary of Citius Pharmaceuticals Inc. announced that it has entered into an exclusive distribution agreement with Uniphar , a leading international healthcare services… read more.
